slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 39,721-39,750
Pages 3,679
Rows per page 30
Component
39,721-39,750 of 110,355
20
The slide uses red annotations and arrows to point out that 'Minimum' values exceed 'Maximum' values in the provided tables, indicating data entry errors.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
21
The slide combines a technical data table with a critical narrative analysis of corporate strategy, suggesting 'desperation' in the company's exploration and development timeline.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
23
This is a text-heavy research note page containing extensive footnotes detailing specific regulatory and geological concerns.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
24
This is a text-heavy research note page focusing on operational underperformance and questionable reporting practices.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose ContradictionLoop · Hypothesis Test1 hit
27
The slide highlights a counter-intuitive outcome where lowering the hurdle for resource classification resulted in a reduction of measured resources.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
28
The slide contains extensive footnotes explaining technical mining terms like Whittle Pits and AISC.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
29
The table highlights a significant discrepancy between previous and updated resource estimates, specifically noting a loss of 140,000 oz of gold and increased mining costs.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
31
The slide uses a table to expose a potential discrepancy in valuation methodology (using a $2,000/oz gold price vs peers' $1,200-$1,500/oz).Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
32
The slide highlights skepticism regarding management's guidance and accounting practices (including receivables in cash).Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
36
The slide is a text-heavy research note page containing critical analysis of financial health and management credibility.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
38
The slide uses a specific historical document (footnote 113) to contrast past management projections with later claims.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
39
Uses the concept of a 'Memory Hole' to frame the company's revisionist history.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
40
The slide uses direct quotes from management and compares them against internal project plan data to highlight inconsistencies.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
41
This is a research note page focusing on corporate governance and transparency issues regarding mining data.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
42
Includes detailed footnotes referencing specific financial reports and news articles.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
43
This is a forensic research note highlighting potential insider selling and obfuscation of ownership.Asanko Gold Inc. (AKG) · Carson C. Block
Research note Short seller Beat · Expose Contradiction1 hit
02
This is a classic activist short-seller research note introduction.OSI Systems, Inc. (OSIS) · Carson C. Block
Research note Short seller 1 hit
03
The slide functions as a narrative-heavy investigative report highlighting potential legal and ethical risks for OSIS.OSI Systems, Inc. (OSIS) · Carson C. Block
Research note Short seller Beat · The MonsterLoop · The Reveal1 hit
04
Includes a pop-culture reference (Robert De Niro in 'Wag the Dog') to frame the narrative of the Albanian government contract.OSI Systems, Inc. (OSIS) · Carson C. Block
Research note Short seller Beat · The MonsterLoop · The Reveal1 hit
05
The slide highlights a transaction where a 49% stake was sold for a nominal value of 490 ALL (~$4.50).OSI Systems, Inc. (OSIS) · Carson C. Block
Research note Short seller Beat · The MonsterLoop · The Reveal1 hit
07
The slide provides evidence of a transaction involving Rapiscan Systems, Inc. and Olti Peçini, referencing specific registration numbers and contract terms.OSI Systems, Inc. (OSIS) · Carson C. Block
Research note Short seller Beat · The MonsterLoop · The Reveal1 hit
08
The slide contrasts formal corporate registry data with investigative journalism regarding a concession.OSI Systems, Inc. (OSIS) · Carson C. Block
Research note Short seller Beat · The MonsterLoop · The Reveal1 hit
02
This is a classic activist short report summary page.Prothena Corp PLC (PRTA) · Carson C. Block
Research note Short seller Beat · Problem (Identify pain)1 hit
03
The text explicitly challenges the interpretation of ASH 2016 data presented by Liedtke et al.Prothena Corp PLC (PRTA) · Carson C. Block
Research note Short seller Beat · Agitate (Make it worse)Loop · Aha Moment1 hit
04
This slide functions as a rebuttal to a specific clinical interpretation of organ response timing.Prothena Corp PLC (PRTA) · Carson C. Block
Research note Short seller Beat · Agitate (Make it worse)1 hit
05
The slide uses a 'before/after' or 'rebuttal' structure by showing an original claim followed by a 'close look' at the data that contradicts the initial interpretation.Prothena Corp PLC (PRTA) · Carson C. Block
Research note Short seller Beat · Agitate (Make it worse)1 hit
06
Includes calculation methodology for 6-12 month response rates.Prothena Corp PLC (PRTA) · Carson C. Block
Research note Short seller Beat · Agitate (Make it worse)1 hit
08
The slide uses a baseball analogy (Mark Whiten) to illustrate the flaw in 'Best Response' metrics.Prothena Corp PLC (PRTA) · Carson C. Block
Research note Short seller Beat · Agitate (Make it worse)1 hit
09
The slide argues that the exclusion of renal dysfunction patients and the lack of dose-response correlation undermine the reported efficacy of NEOD001.Prothena Corp PLC (PRTA) · Carson C. Block
Research note Short seller Beat · Agitate (Make it worse)1 hit
10
The slide functions as a critical analysis of clinical trial data and market potential for a drug candidate.Prothena Corp PLC (PRTA) · Carson C. Block
Research note Short seller Beat · Solution (Provide relief)1 hit